"Patients are seen at our Northeast GI Research location by appointment only. This office is not open to regular patient visits."

During the past decade, Northeast GI Research Division conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeast GI Research Division" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Enanta Pharmaceuticals, Inc" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Guardant Health, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast GI Research Division" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Northeast GI Research Division" are "Nonalcoholic Steatohepatitis" (3 trials), "Colorectal Cancer" (1 trials), "Hepatic Cirrhosis" (1 trials), "Liver Fibrosis" (1 trials) and "Non-Alcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Northeast GI Research Division" in a lesser frequency.

Most popular intervention types in "Northeast GI Research Division" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BI 456906" (1 trials), "BMS-986036" (1 trials), "Cenicriviroc" (1 trials) and "Cilofexor (CILO)/Firsocostat (FIR)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northeast GI Research Division" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Northeast GI Research Division". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Northeast GI Research Division, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northeast GI Research Division, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".